Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
quote
AKBA – Akebia Therapeutics, Inc. –
AKBA – Akebia Therapeutics, Inc. –
Quotes
Charts
News & Analysis for AKBA
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Other Events
ME Staff 8-k
-
May 12, 2020
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Other Events
ME Staff 8-k
-
April 20, 2020
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Entry into a Material...
ME Staff 8-k
-
April 8, 2020
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
April 7, 2020
0
Akebia Therapeutics Inc (NASDAQ:AKBA) Insider Trading Activity – SVP Bought 27,000...
ME Staff
-
November 22, 2019
0
Akebia Therapeutics Inc (NASDAQ:AKBA) Insider Trading Activity – CEO Bought 50,000...
ME Staff
-
November 21, 2019
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Results of Operations and...
ME Staff 8-k
-
August 8, 2019
0
Akebia Therapeutics Inc (NASDAQ:AKBA) had its Buy ➝ Buy rating reiterated...
ME Staff
-
August 6, 2019
0
Akebia Therapeutics Inc (NASDAQ:AKBA) price target lowered to $21.00 by HC...
ME Staff
-
July 11, 2019
0
Akebia Therapeutics Inc (NASDAQ:AKBA) has coverage initiated with a Neutral rating
ME Staff
-
March 20, 2019
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Results of Operations and...
ME Staff 8-k
-
March 18, 2019
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Entry into a Material...
ME Staff 8-k
-
December 13, 2018
0
Akebia Therapeutics Inc (NASDAQ:AKBA) had its Buy rating reiterated by Mizuho...
ME Staff
-
December 4, 2018
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
November 16, 2018
0
Akebia Therapeutics Inc (NASDAQ:AKBA) has coverage initiated with a Equal ➝...
ME Staff
-
September 7, 2018
0
Akebia Therapeutics Inc (NASDAQ:AKBA) price target lowered to $18.00 by Needham...
ME Staff
-
August 10, 2018
0
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Files An 8-K Entry into a Material...
ME Staff 8-k
-
June 28, 2018
0
AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Submission of Matters to...
ME Staff 8-k
-
June 15, 2018
0
Load more